Announcement on Voluntary Disclosure of Information Regarding Multiple Studies on Golidocitinib (Gaoruize) and Birelentinib Included in the 67th Annual Meeting of the American Society of Clinical Hematology (ASH)

About this update from Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A

Announcement on Voluntary Disclosure of Information Regarding Multiple Studies on Golidocitinib (Gaoruize) and Birelentinib Included in the 67th Annual Meeting of the American Society of Clinical Hematology (ASH)The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Dizal (jiangsu) Pharmaceutical Co. Ltd. Class A